Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001549595-24-000116

Chief Legal Officer sold 9,050 shares at an average $24.94 ($225,736)

  • Chief Legal Officer acquired 9,050 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · Chief Legal Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-03 Exercise or conversion : show line 1 in the form 10b5-1 +5,760 $1.86 $10,714 30,352 D
2024-09-03 Exercise or conversion : show line 2 in the form 10b5-1 +3,290 $9.57 $31,485 33,642 D
2024-09-03 Sale : show line 3 in the form 10b5-1 −8,850 $24.93 $220,612 24,792 D
2024-09-03 Sale : show line 4 in the form 10b5-1 −200 $25.62 $5,124 24,592 D
Open-market sales · 9,050 sh · avg $24.94 · $225,736

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-09-03 Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) −5,760 77,026 D
2024-09-03 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) −3,290 102,969 D
Loading xslF345X05/wk-form4_1725399182.xml…